TET2 and mature T-cell and NK-cell non-Hodgkin lymphoma: The genetic basis of PTCL revealed that EBER-positive and partially positive patients were more likely to harbor DNMT3A (P = 0.002), RHOAG17V (P = 0.023), and TET2 mutations (P = 0.032).